Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative HALO - Halozyme Therapeutics, Inc.
149 M
LAST VALUE
72.18%
2 YEAR CAGR
19.66%
5 YEAR CAGR
16.52%
10 YEAR CAGR